Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Der p 10Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE865.81320101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164082.62020100301, Scala E
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE761.30020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE352.86020130605, Simon D
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE962.08020120528, Patelis A
1.4 - Respiratory Symptoms, Diagnosed2014AustriaIgE4210.00020140707, Banerjee S
1.5 - Atopic Dermatitis, Diagnosed2014AustriaIgE567.00020140707, Banerjee S
1.5 - Atopic Dermatitis, Diagnosed2014GermanyIgE10025.00020140707, Banerjee S
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1402.14020130111, Ott H
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2020.00020091005, Ott H
1.5 - Atopic Dermatitis, Diagnosed2014Korea, Republic ofIgE258.00020140821, Choi JS
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
3.2.1 - Source Sensitized (IgE)2003AustriaIgE2010.000
3.2.1 - Source Sensitized (IgE)2003ZimbabweIgE2055.000
3.2.1 - Source Sensitized (IgE)1998SpainIgE (IB)715.600
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2213.64020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2014SingaporeIgE3831.60020140926, Thalayasingam M
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2008SwedenIgE313.00020081121, Weghofer M
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2014SingaporeIgE2714.80020140926, Thalayasingam M
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE370.00020090826, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011SpainIgE3666.66020110609, Gamez C
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011SpainIgE90.00020110609, Gamez C
5.1.1 - Source Exposed (Symptoms)2013GermanyIgE984.08020130501, Becker S
5.2.1 - Source Exposed (Symptoms, SPT)2004Australia / AustriaIgE786.400
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE482.20020141122, Morales M
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE454.70020141122, Morales M
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE434.70020141122, Morales M
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE330.00020141122, Morales M
5.2.1 - Source Exposed (Symptoms, SPT)2011SpainIgE400.00020110228, Boquete M
5.2.1 - Source Exposed (Symptoms, SPT)2011SpainIgE2532.00020110228, Boquete M
5.2.5 - Source Exposed, Children (Symptoms, IgE)2006AustraliaIgE1058.60020060524, Hales BJ
5.3.1 - Source Exposed (Symptoms, IgE)2006AustraliaIgE7728.60020060524, Hales BJ
5.3.1 - Source Exposed (Symptoms, IgE)2008AustriaIgE5618.00020081121, Weghofer M
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE995.05020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2007ColombiaIgE9016.70020080220, Jimenez S
5.3.1 - Source Exposed (Symptoms, IgE)2008FranceIgE559.00020081121, Weghofer M
5.3.1 - Source Exposed (Symptoms, IgE)2008ItalyIgE6710.00020081121, Weghofer M
5.3.1 - Source Exposed (Symptoms, IgE)2014SingaporeIgE3821.10020140926, Thalayasingam M
5.3.1 - Source Exposed (Symptoms, IgE)2008SwedenIgE6518.00020081121, Weghofer M
5.3.2 - Source Exposed (Symptoms, high IgE)2012FranceIgE12327.64020120521, Bronnert M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011AustriaIgE132215.20020110629, Resch Y
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012FranceIgE1910.53020120622, Casset A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012ItalyIgE2619.23020120622, Casset A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011SingaporeIgE2257.00020110221, Kidon MI
6.2 - General Population (Adults)2012SwedenIgE3710.81020120528, Patelis A
Developed by
Panservice